Cargando…
Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods
The current global health emergency in the form of the Coronavirus 2019 (COVID-19) pandemic has highlighted the need for fast, accurate, and efficient drug discovery pipelines. Traditional drug discovery projects relying on in vitro high-throughput screening (HTS) involve large investments and sophi...
Autores principales: | Choudhury, Chinmayee, Arul Murugan, N., Priyakumar, U. Deva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920090/ https://www.ncbi.nlm.nih.gov/pubmed/35301148 http://dx.doi.org/10.1016/j.drudis.2022.03.006 |
Ejemplares similares
-
Advances in the computational landscape for repurposed drugs against COVID-19
por: Aronskyy, Illya, et al.
Publicado: (2021) -
AI-based language models powering drug discovery and development
por: Liu, Zhichao, et al.
Publicado: (2021) -
Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents
por: Han, Jinhe, et al.
Publicado: (2022) -
The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects
por: Qiu, Tingting, et al.
Publicado: (2021) -
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
por: Chavda, Vivek P., et al.
Publicado: (2021)